Go!
Go!


Wednesday, February 18, 2009

Volume 3, Issue #12

Printer-Friendly | Whitelist Us
Doubling Your Money in Hours, Not Years
-- By Jim Nelson, Managing Editor, Penny Sleuth
For today's issue of TopStockAnalysts Digest, we are pleased to have Jim Nelson as our guest contributor. Jim Nelson is the managing editor of Penny Sleuth, and a contributor to Penny Stock Fortunes. Today, he's going to explain how a security bought Friday afternoon can be cashed out Monday morning for +149% gain.  Find out what criteria Jim uses to spot stocks that can double your money in a matter of hours.

Also in Today's Issue...

Texas Snowboarder Reveals "Secret Code" for Making Millions
It was in a cabin in the Texas desert where this snowboarder cracked what appears to be the "secret code" to Wall Street's millions -- a formula that made him $1,000,000 in just 3 years.

Thousands of investors who have followed this "secret code" have pulled in returns of up to +2,000% and more.

Now it's your turn.

"Fed Approved" Bank Expects Earnings to Spike +38% Next Year
You don't have to worry about the threat of bad loans with this bank. The government says it's healthy enough to survive two more years of bad economic conditions without a penny of new capital. And best of all its preferred shares yield 10.1%. With this bank you could have the rare opportunity to collect a safe, double-digit yield and benefit from the company's growing earnings.

Don't miss out on what it does in the next 12 months.

Get the report on this bank now.

Doubling Your Money in Hours, Not Years
On the morning of January 12, 2009, the sun was shining extra bright for one Southern Californian firm. The small specialized health care business of Advanced Medical Optics (NYSE: EYE) experienced a truly perfect day. At least, its investors did.

You see, Abbott Laboratories announced that it intends to acquire AMO for $22 per share in cash. That's about 149% above it's $8.85 Friday close. It took 18 years for the S&P 500 to bring those kinds of gains. Seriously, you'd have had to invest in February 1991 to realize a 149% gain today.

Most investment advisors compare their expected returns to benchmark indexes like the S&P 500 or the Dow Jones. Even small-cap specialists compare their gains to the Russell 2000. But, why in the world would you want to wait 18 years to grow your money, when there are investments you can buy on a Friday afternoon and cash out on Monday for the same return.

So the question before us is: how can you double your money like AMO investors?

AMO is a rare case when investors oversold a company's stock and a large competitor takes advantage. To benefit from cases like these, you need to find similar scenarios. Let's walk through AMO's story...

Finding a Mega Value

AMO sells vision-correction technologies and products for a wide variety of patients. For instance, no one sells more LASIK surgical devices - used in more than 90 percent of all U.S. refractive surgical procedures - than AMO. The company also holds the number two spot in the cataract surgical devices market and the number three position in the contact lens products market.

Now, without serious research there's simply no way for me to tell you any more than that. Frankly, I don't know much about this industry, and since the jump already occurred, I don't need to.

But apparently, Abbott Laboratories did do that research and figured that AMO was still a buy at a 148% premium. The point is, Abbott realized how important it was to control the top spots in these fields.
Special Offers

Get Investor's Business Daily FREE for two weeks.
Learn More

Risk free trial of our live e-mini futures trading room.
Learn More

 

Over 60% of 60+ year olds have cataracts. In the next 11 years, the number of 60+ year olds globally is expected to increase 43%. Simply put... the older you are, the more chances you'll need AMO's technologies. And with more older people than ever, the demand is rising. You don't have to be an eye expert to realize what Abbott was thinking.

On top of a great looking future, AMO was also incredibly cheap just last week. Abbott is basically paying a total $2.8 billion for a company that produces $1.1 billion in revenue per year. In just two and a half years, the company's revenue will merit the investment.

Sure, it's not a highly profitable company yet, but it is in the black. AMO is already turning a profit, which is just another stream of income for Abbott even before synergies are realized.

Back to how this affects you...

If you know what to look for, you can be in on the next AMO. Below is a quick list of criteria to look for when searching for a buyout candidate:

      Value - are the company's price-to-earnings, price-to-sales, and price-to-cash     
       flow ratios low?
      ROI - has the company made smart investment decisions? Will there be a lot of
       useless intangible assets lying around that would disinterest a potential owner?
      Industry - is the company in a growing or contracting industry? Is it an industry 
       that is conducive to mergers and acquisitions?
      Profit - is the company profiting already, or at least have a profitable horizon?
      Debt - is the company carrying high debt? Would a potential buyer use the debt
       situation to lower its buying price?
     Synergy - is the company's business model flexible, and can a potential buyer save
       costs by synergizing departments?

Of course, each company is different, and each acquisition is different. It takes some serious studying to find great buyout candidates. But done right, and you can save yourself 18 years of waiting around in the stock market. If you find the right candidate, you might just multiply your money in hours, not years.

Sincerely,


--Jim Nelson
Managing Editor
Penny Sleuth


P.S.: Rumor has it that one of the picks in the Penny Stock Fortunes is about to get bought out. If that's true, members will be able to pay for their subscription immediately with enough cash left over to take a vacation, buy a new flat-screen, or pay for a semester of their children's college tuition. Heck, you can use this money any way you want. Imagine what it'd be like to double or triple your money in just a few hours. Check it out here...


Pick-Up Game

India has some important lessons to teach about sector formation in emerging economies. For example, as an emerging market grows, which of these industries is one of the first to develop?
 
A.) Aerospace
B.) Banking
C.) Restaurants
D.) Advertising
E.) Media

(Please click on one the links above. After you make your choice, we'll show you the correct answer on our web site.)

Nathan Slaughter
Co-Editor
TopStockAnalysts Digest


Paul Tracy
Co-Editor
TopStockAnalysts Digest



 

 

TopStockAnalysts
http://www.TopStockAnalysts.com
839-K Quince Orchard Blvd. 
Gaithersburg, MD 20878-1614

P.S. -- If you're not already a subscriber to one of StreetAuthority.com's premium investing newsletters, which include a wealth of additional information and specific investing guidance that you won't find anywhere else, then please visit the following page to learn more: http://www.StreetAuthority.com/subscribe.asp


.

TopStockAnalysts Digest Web Site Content...

.

 

You are receiving this newsletter because you visited us at TopStockAnalysts.com and registered to receive our complimentary biweekly investing newsletter -- TopStockAnalysts Digest. If you feel you have received this issue in error, please follow the instructions below to unsubscribe or contact us by visiting our web site.

If you are interested in advertising in this newsletter, or on our web site, please visit this link.

This message was sent by an automated message delivery platform. Please do not reply to this email address. Any messages sent to this address will be automatically deleted. We sincerely hope that you benefit from your subscription to this complimentary newsletter, and we're willing to do whatever it takes to keep you as a satisfied customer. However, if at any time you wish to discontinue your subscription, you can do so by simply visiting this link and confirming your request, or by calling (301) 216-2005.

Please note that TopStockAnalysts is not a registered investment firm or broker/dealer. Readers are advised that the material contained herein should be used solely for informational purposes. TopStockAnalysts does not purport to tell or suggest which investment securities members or readers should buy or sell for themselves. Site users should always conduct their own research and due diligence and obtain professional advice before making any investment decision. TopStockAnalysts will not be liable for any loss or damage caused by a reader's reliance on information obtained in this newsletter or on our web site. Our readers are solely responsible for their own investment decisions.

The information contained herein does not constitute a representation by the publisher or a solicitation for the purchase or sale of securities. Our opinions and analyses are based on sources believed to be reliable and are written in good faith, but no representation or warranty, expressed or implied, is made as to their accuracy or completeness. All information contained in this report should be independently verified with the companies mentioned. The editor and publisher are not responsible for errors or omissions. Any opinions expressed are subject to change without notice. Owners, employees and writers may hold positions in the securities discussed in this report or on our web site.

Copyright 2001-2009 TopStockAnalysts. All rights reserved.
Unauthorized reproduction or distribution is strictly prohibited.


Meet the Experts    Email Newsletters    Special Offers    Email Preferences    FAQ
About Us    Advertise    Links    Privacy    Disclaimer    Help


TopStockAnalysts button StreetAuthority button Dividend Opportunities button

(c) Copyright 2001-2009 TopStockAnalysts.com -- All Rights Reserved